Abstract:Objective To investigate the effect of ginseng protein(GP)on neurons damaged by beta amyloid protein1-40(Aβ1-40)and hydrogenperoxide(H2O2),and to clarify the neuroprotective effect of GP and its mechanism.Methods The primary neurons were isolated and purified from cerebral cortex of suckling mouse and cultured for 12d,and damaged by 30μmol·L-1 Aβ1-40and 200μmol·L-1 H2O2.Then the damaged cells were randomly divided into model group(Aβ1-40model group and H2O2 model group,no drugs),GP group and GP medicated serum group.MTT method was used to detect the survival rates of cells;Qiagen was used to detect the activities of NOS and levels of NO in culture supernatant,and Hoechst 33342/PI fluorescent staining method was used to detect the apoptotic and necrotic rates of cells.Results It was observed that by the treatment of Aβ1-40and H2O2,the number of neuron was decreased,the axons shortened or disappeared,the karyopyknosis concentrated into a bright blue(dyed by Hoechst 33342),and some cells were dyed into red by PI under inverted flurescence microscope;after adding GP and its medicated serum,the number of cells was obviously increased,the cells stretched,the nuclei were round and light blue,and the number of cells dyed by PI into red was reduced.The MTT results showed that the survial rate of cells in GP group was obviously higher than that in model group(P0.05or P0.01).There was no significant difference in the survival rate of cells between GP medicated serum group and model group(except 5% GP medicated serum group,P0.05).The activity of NOS and level of NO in culture supernatant in GP group were significantly lower than those in model group(P0.05or P0.01).The apoptotic rates of cells in GP group and GP medicated serum group were obviously lower than that in model group detected by Hoechst 33342/PI method(P0.05or P0.01).There was no significant differences of the necrotic rates of neurons between GP group,GP medicated group and model group(P0.05).Conclusion GP protein has the neuroprotective effect,and its mechanism is related to the reduction of the activity of NOS and the level of NO and the inhibition of apoptosis of neurons.

Neuroprotective Effects of Ginseng Protein on PI3K/Akt Signaling Pathway in the Hippocampus of D -Galactose/alcl 3 Inducing Rats Model of Alzheimer’s Disease

Ginseng Protein Reverses Amyloid Beta Peptide and H2o2 Cytotoxicity in Neurons, and Ameliorates Cognitive Impairment in Ad Rats Induced by A Combination of D-Galactose and Alcl3

STUDY ON METABONOMICS MECHANISM OF COMPATIBILITY OF GINSENOSIDES AND TENUIGENINS ON ALZHEIMER’S DISEASE RATS BASED ON UPLC-MS

Ginseng Improves Cognitive Deficit Via the RAGE/NF-κB Pathway in Advanced Glycation End Product-Induced Rats

Ginsenoside Rg1 Ameliorates Behavioral Abnormalities and Modulates the Hippocampal Proteomic Change in Triple Transgenic Mice of Alzheimer's Disease

The neuroprotective effect of ginsenoside Rb1 on the cerebral cortex changes induced by aluminium chloride in a mouse model of Alzheimer's disease: A histological, immunohistochemical, and biochemical study

Protective effects of ginsenoside Rg2 against memory impairment and neuronal death induced by Aβ25-35 in rats

A 4.7-Kda Polysaccharide from Panax Ginseng Suppresses Aβ Pathology Via Mitophagy Activation in Cross-Species Alzheimer’s Disease Models

Ginsenoside Rg1 Ameliorates the Cognitive Deficits in D-galactose and AlCl3-induced Aging Mice by Restoring FGF2-Akt and BDNF-TrkB Signaling Axis to Inhibit Apoptosis

Ginsenoside Rg1 Ameliorates Alzheimer's Disease Pathology Via Restoring Mitophagy

Protective effect of ginseng protein on neurons damaged by amyloid-β protein1-40 and H2O2 and its mechanism

Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway

Ginsenoside Rg1 Decreases A Beta(1-42) Level By Upregulating Ppar Gamma And Ide Expression In The Hippocampus Of A Rat Model Of Alzheimer'S Disease

Ginsenoside Rg2 alleviates neurovascular damage in 3xTg-AD mice with Alzheimer's disease through the MAPK-ERK pathway

Ginsenoside Rg1 alleviates learning and memory impairments and Aβ disposition through inhibiting NLRP1 inflammasome and autophagy dysfunction in APP/PS1 mice

Ginsenoside Rg1 Prevents Cognitive Impairment and Hippocampus Senescence in a Rat Model of D-Galactose-Induced Aging

Ginsennoside Rd Attenuates Cognitive Dysfunction in a Rat Model of Alzheimer’s Disease

Unraveling the therapeutic potential of ginsenoside compound Mc1 in Alzheimer’s disease: Exploring the role of AMPK/SIRT1/NF-κB signaling pathway and mitochondrial function

Involvement of GSK3 and PP2A in ginsenoside Rb1's attenuation of aluminum-induced tau hyperphosphorylation

Effect of ginsenoside Rb1 on expression of β-secretase and presenilin-1 in hippocampal formation of Alzheimer's disease-like rats

Ginsenoside Rg5 Improves Cognitive Dysfunction and Beta-Amyloid Deposition in STZ-induced Memory Impaired Rats Via Attenuating Neuroinflammatory Responses.